Gonzalez-Casas Rosario, Jones E Anthony, Moreno-Otero Ricardo
Digestive Disease Service and Center for Investigation of Hepatic and Digestive Diseases, University Hospital La Princesa, Autonomous University of Madrid, Madrid 28006, Spain.
World J Gastroenterol. 2009 Oct 7;15(37):4653-8. doi: 10.3748/wjg.15.4653.
Anemia of diverse etiology is a common complication of chronic liver diseases. The causes of anemia include acute or chronic gastrointestinal hemorrhage, and hypersplenism secondary to portal hypertension. Severe hepatocellular disease predisposes to hemorrhage because of impaired blood coagulation caused by deficiency of blood coagulation factors synthesized by hepatocytes, and/or thrombocytopenia. Aplastic anemia, which is characterized by pancytopenia and hypocellular bone marrow, may follow the development of hepatitis. Its presentation includes progressive anemia and hemorrhagic manifestations. Hematological complications of combination therapy for chronic viral hepatitis include clinically significant anemia, secondary to treatment with ribavirin and/or interferon. Ribavirin-induced hemolysis can be reversed by reducing the dose of the drug or discontinuing it altogether. Interferons may contribute to anemia by inducing bone marrow suppression. Alcohol ingestion is implicated in the pathogenesis of chronic liver disease and may contribute to associated anemia. In patients with chronic liver disease, anemia may be exacerbated by deficiency of folic acid and/or vitamin B12 that can occur secondary to inadequate dietary intake or malabsorption.
多种病因引起的贫血是慢性肝病常见的并发症。贫血的原因包括急性或慢性胃肠道出血,以及门静脉高压继发的脾功能亢进。严重的肝细胞疾病易发生出血,这是由于肝细胞合成的凝血因子缺乏导致凝血功能受损,和/或血小板减少。再生障碍性贫血以全血细胞减少和骨髓细胞减少为特征,可在肝炎发展后出现。其表现包括进行性贫血和出血表现。慢性病毒性肝炎联合治疗的血液学并发症包括临床上显著的贫血,继发于利巴韦林和/或干扰素治疗。减少药物剂量或完全停药可逆转利巴韦林引起的溶血。干扰素可能通过诱导骨髓抑制导致贫血。酒精摄入与慢性肝病的发病机制有关,可能导致相关贫血。在慢性肝病患者中,叶酸和/或维生素B12缺乏可因饮食摄入不足或吸收不良而继发,从而加重贫血。